Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-23T14:38:48.584Z Has data issue: false hasContentIssue false

An evaluation of Portuguese radiation oncologists knowledge and practice in relation to geriatric oncology

Published online by Cambridge University Press:  16 January 2025

Edna Darlene Rodrigues Pinto*
Affiliation:
ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal CINTESIS – Center for Health Technology and Services Research, Porto, Portugal
Paulo Almeida
Affiliation:
Internal Medicine Department, Centro Hospitalar Universitário de São João, E.P.E, Porto, Portugal
Escarlata López
Affiliation:
Radiation Oncology Department, GenesisCare, Málaga, Spain
Laetitia Teixeira
Affiliation:
ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal CINTESIS – Center for Health Technology and Services Research, Porto, Portugal
*
Corresponding author: Edna Darlene Rodrigues Pinto; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Cancer is a major health concern in Portugal, especially among older adults, who represent nearly half of new cases. Radiation therapy (RT) is crucial in their treatment, emphasizing the need for improved education in geriatric oncology for radiation oncologists (RO).

Methods:

A pretested 22-item online survey on RO’s geriatric oncology knowledge was disseminated.

Results:

The analysis involved 52 respondents, including 13 residents (25%) and 39 consultants (75%); RO were asked to specify the age threshold they considered to define an older cancer patient. Their responses were as follows: 60 years (n = 2, 3·8%), 65 years (n = 7, 13·5%), 68 years (n = 1, 1·9%), 70 years (n = 29, 55·8%), 75 years (n = 10, 19·2%) and 80 years (n = 2, 3·8%). Forty-six respondents (88·5%) acknowledged an observed increase in the number of older cancer patients in RT departments. Twenty-nine participants (55·8%) reported that age was considered either most of the time or always in clinical decisions. Regarding frailty screening, it was performed by 15 participants (28·8%), while four participants (7·7%) stated that frailty was assessed during comprehensive geriatric assessment in another department. Of those implementing screening tools, nine (17·3%) utilized the G8 tool, and two respondents (3·8%) employed the Triage Risk Screening Tool. Most respondents reported a lack of awareness regarding specific guidelines for older cancer patients, and 98·1% expressed the need for enhanced training in geriatric oncology.

Conclusion:

The study highlights a critical need for improved training in geriatric oncology among RO professionals. Furthermore, the findings underscore the imperative for treatment decisions to reflect an understanding beyond chronological age, emphasizing the necessity of addressing this knowledge gap in clinical practice.

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - SA
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (https://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is used to distribute the re-used or adapted article and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Highlights

  • The analysis encompassed 52 respondents, primarily consisting of 75% RO consultants and 25% residents, falling short of the intended sample size.

  • Findings, reported with a 90% confidence level and 10% margin of error, highlighted a predominantly female representation (56.6%) and a significant proportion (51.9%) working in university hospitals.

  • Radiation oncologists’ expertise spanned various cancer subtypes, with age significantly influencing clinical decision-making. Frailty assessment was underutilized.

  • Despite limited awareness of guidelines specific to older cancer patients and sparse staff resources for comprehensive geriatric assessments, there was a recognized need for enhanced training in geriatric oncology among respondents.

Introduction

In the Portuguese context, cancer is the second major cause of both mortality and morbidity, accounting for 28,544 cancer-related deaths, approximately constituting 25% of the overall mortality. 1 Notably, nearly half of these new cancer cases occur within the older adult population aged above 70 y/o or over. Reference Costa Miranda, Mayer-da-Silva, Glória and Brito2 Approximately 45–55% of new cancer cases may require radiation therapy (RT), with an expected 20–30% increase due to demographic changes. RT is commonly used in older adults with cancer, often alongside surgery, chemotherapy, and/or immunotherapy. Reference Borras, Lievens and Dunscombe3

Older cancer patients frequently formulate treatment decisions based upon a basis of trust in their healthcare providers, adhering to the recommendations offered by their physicians. Reference Puts, Tapscott and Fitch4 Physicians, especially radiation oncologists (RO), should acknowledge that the predictive value of chronological age in assessing tolerance and outcomes for older adults with cancer is limited. In light of this recognition, treatment decisions must be informed by an understanding of the complex interplay of factors influencing the health and outcomes of this population. Reference O’Donovan and Leech5 One of the most important concepts in this context is frailty, a multisystem syndrome characterized by diminished physiological reserves, mirroring alterations across tissues and organs. This phenomenon is intricately linked with geriatric syndromes, multimorbidity, and the physiological changes such as senescence, collectively reflecting ageing’s complexity. Reference Thillainadesan, Scott and Le Couteur6

There is a growing emphasis on personalized and patient-centred approaches. Within this context, the perspectives of RO on geriatric oncology play a critical role in shaping treatment strategies for older cancer patients. Despite the increasing recognition of the challenges associated with cancer in the geriatric population, a notable gap exists in the literature regarding the specific viewpoints of RO on geriatric oncology in the context of Portugal, where there is no specialized geriatric medical specialty.

Given the 2021 statistics indicating 172 (80%) registered consultants and 43 (20%) residents in radiation oncology across Portugal, training initiatives should be strategically tailored to meet the specific needs and availability of both residents and consultants. 711 The findings from this research can play a pivotal role in enhancing existing training programmes, ensuring that RO, including both residents and experienced consultants, are adequately equipped to navigate the distinctive challenges inherent in the treatment of older cancer patients.

Moreover, given the critical role of RT in improving outcomes for older adults with cancer, there is a pronounced need for improved educational initiatives within the domain of geriatric oncology. Reference Morris, Thiruthaneeswaran, Lehman, Hasselburg and Turner12,Reference Terret and Droz13 RO must anticipate and address the unique needs of older patients, with a focus on having access to frailty status, ideally assessed through a Comprehensive Geriatric Assessment (CGA). When such an assessment is not available, RO must be familiar with frailty screening tools. Reference O’Donovan and Leech5 Additionally, it is important to enhance communication by directly assessing information needs, balancing realism with hope, recognizing non-survival goals, and employing techniques to reduce miscommunication. Reference Fakhreddine, Galvan, Pawlowski and Jones14 This research aimed to examine the understanding of geriatric oncology among Portuguese RO, with the objective of assessing their current knowledge in this field.

Methods

Ethics

This study was approved by Research Ethics Committee from the School of Medicine and Biomedical Sciences, University of Porto, Portugal (reference 2021/CE/P026 (P366/CETI/ICBAS). Informed consent was obtained for all the participants.

Development of the survey instrument

A 22-item online survey assessing RO’s perspectives in geriatric oncology underwent a pretest with 10 individuals from Centro Hospitalar Universitário São João’s Radiotherapy Department to ensure consistency and content clarity. This survey was developed based on literature review and investigator consensus. Reference Leifer, Bristow and Puts15 Some questions found in the literature were adapted to the Portuguese reality and to the absence of geriatrics as an established specialty in the country. After refining the pretest, the finalized survey was distributed. The final distributed version of the survey is available on supplementary data.

The questionnaire covered RO characteristics (gender, age, professional details, cancer type experience), institutional factors (type, geriatric assessment availability), geriatric knowledge (training, age categorization), patient management (age-related treatment variations, informal/formal geriatric assessments, frailty screening), awareness of international recommendations for older cancer patients and future training needs. The question about the use of frailty screening tools included Geriatric-8 (G8), Vulnerable Elders Survey-13 (VES-13) and Triage Risk Screening Tool. These were selected based on previous publications that state that an abnormal result on these has been established as associated with functional decline and poorer survival. Reference Loh, Soto-Perez-de-Celis and Hsu16 The authors aimed to increase awareness about International Geriatric Radiotherapy Group, so a question asking about it was created. This group was founded in 2012 by 15 radiotherapy institutions in the United States and Europe and aims to improve radiotherapy techniques for older cancer patients, enhancing their chances of cure and quality of life. Reference Popescu, Karlsson and Vinh-Hung17

Participants

The study encompassed RO (consultants and residents) actively involved in cancer patient care in Portugal. The entire eligible cohort comprised 43 residents and 172 consultants, identified through the Portuguese Medical Council statistics database. The sample size was estimated to be 139, with 95% confidence level and a margin of error of 5%. The online survey was distributed to department directors and presented during in-person meetings across five Portuguese radiotherapy departments. The responses were obtained between November 2021 and April 2022. No financial incentives were provided for survey completion, and based on pilot testing, the survey was designed to be completed in less than 10 min.

Data analysis

We conducted summary descriptive analyses on responses obtained from this survey. Also, the pattern of responses was compared between consultants and residents. The survey confidence level and margin of error were calculated according to Serdar et al. Reference Serdar, Cihan, Yucel and Serdar18

We employed crosstab analysis to compare frailty screening and CGA utilization rates between residents and consultants. IBM® SPSS® Statistics version 27 and Microsoft Office 365 Apps for Enterprise—Excel® were employed for conducting both descriptive and statistical analyses.

Statistical significance was considered to differences with a p-value below 0·05.

Results

In this analysis, 52 respondents were included, comprising 13 residents (25%) and 39 consultants (75%) in RO. The estimated sample size of 139 was not met, and the outcomes of this study are reported with a confidence level of 90% and a margin of error of 10%. Of the total respondents, 31 (56·6%) were female, and 27 (51·9%) worked at a university hospital. Consultant expertise covered various cancer subtypes: genitourinary (n = 15, 28·8%), breast (n = 15, 28·8%), gastrointestinal (n = 13, 25%), head and neck (n = 13, 25%), lung (n = 11, 21·2%), central nervous system (n = 7, 13·5%), haematology (n = 9, 17·3%), gynaecology (n = 6, 11·5%) and skin/sarcomas (n = 6, 11·5%).

In relation to pre-graduate training in geriatrics within the context of RO, four participants (7·7%) reported having received such training. Post-graduate training in geriatrics was reported by one respondent (1·9%). Seven respondents (13·5%) indicated the presence of a designated professional for geriatric oncology within their respective hospitals. However, only six participants (11·5%) affirmed the availability of staff resources for the implementation of a CGA.

More than half of the RO considered 70 years old as the threshold for defining an older cancer patient, as illustrated in Figure 1.

Figure 1. Representation of the age thresholds that radiation oncologists considered for defining a cancer patient as older.

The clinical decision-making process was predominantly influenced by age, with 29 participants (55·8%) reporting that age was considered either most of the time or always. Concerning awareness of guidelines specific to older cancer patients, 26 respondents (50%) reported familiarity with National Comprehensive Cancer Network—NCCN Older Adult Oncology Guidelines, 13 (25%) with American Society of Clinical Oncology—ASCO, three (5·8%) with International Society of Geriatric Oncology—SIOG, 19 (36·5%) with European Organisation For Research And Treatment Of Cancer—EORTC, and 17 (32·7%) indicated awareness of none. Most respondents, comprising 38 individuals (73·1%), indicated a lack of awareness regarding the International Geriatric Radiotherapy Group. Regarding frailty screening, it was performed by 15 participants (28·8%), while four participants (7·7%) stated that frailty was assessed during CGA in another department. Of those implementing screening tools, nine (17·3%) utilized the G8 tool, and two respondents (3·8%) employed the Triage Risk Screening Tool.

In routine clinical practice, RO reported assessing various domains of older persons, encompassing walking (n = 13, 25%), activities of daily living (n = 34, 65·4%), instrumental activities of daily living (n = 4, 7·7%), nutrition (n = 7, 13·5%), cognition (n = 23, 44·2%), depression (n = 2, 3·8%), comorbidities (n = 10, 19·2%), social aspects (n = 27, 51·9%), polypharmacy (n = 22, 42·3%) and falls (n = 11, 21·2%).

A significant proportion, 46 respondents (88·5%), acknowledged an observed increase in the number of older cancer patients attending RO departments. Furthermore, 51 participants (98·1%) expressed the need for enhanced training in geriatric oncology. The preferred methods for training included case studies discussions (n = 27, 51·9%), workshops (n = 23, 44·2%), constitution of cancer type-specific interest groups (n = 26, 50%) and easy access to international geriatric oncology guidelines (n = 34, 65·4%).

There were no significant differences between the answers from consultants and residents for all the questions, as shown in Table 1 and Figure 2.

Table 1. Comparison of responses between residents and consultants in radiation oncology

ADL, Activities of daily living; ASCO, American Society of Clinical Oncology; CGA, Comprehensive geriatric assessment; EORTC, European Organisation for Research and Treatment of Cancer; G8, Geriatric 8; IADL, Instrumental activities of daily living; NA, Not applicable; RO, Radiation Oncology; TRST, Triage Risk Screening Tool; VES-13, Vulnerable Elders-13 Survey; SIOG, International Society of Geriatric Oncology.

Figure 2. Comparison between responses within residents and consultants in radiation oncology (RO), regarding their training needs and preferences.

Discussion

This analysis involved 52 respondents, including 13 residents (25%) and 39 consultants (75%) in RO, with diverse expertise covering various cancer subtypes. Most of the respondents reported a lack of awareness regarding guidelines for older cancer patients, and 98·1% expressed the need for enhanced training in geriatric oncology. The preferred training methods included case studies discussions, workshops, constitution of cancer type-specific interest groups and easy access to international geriatric oncology guidelines.

Our findings indicate that a minority of respondents had received training in geriatrics. This aligns with the outcomes of a cross-sectional online survey distributed across 45 cancer centres in Australia, New Zealand and Singapore, revealing that 91·8% of respondents had not undergone any formal or informal instruction related to geriatric oncology during their radiation oncology training. Reference Morris, Thiruthaneeswaran, Lehman, Hasselburg and Turner19 Our findings, in conjunction with literature, highlight that the lack of training in geriatrics is common among RO regardless of the country of practice.

Approximately half of the survey participants mentioned that age significantly impacts clinical decision-making. Unfortunately, this trend aligns with findings from a comprehensive scoping review, emphasizing the prevalent use of patient age, either explicitly or implicitly and consciously or unconsciously, as a determinant in guiding clinical decisions in cancer care. Reference Tranvag, Norheim and Ottersen20 Additionally, there is evidence that healthcare professionals have negative biases toward older women with breast cancer resulting in less optimal care. Neal et al performed a study that used the Implicit Association Test to assess healthcare professionals’ biases toward older women, revealing a moderate negative implicit association with older women (M = 0·52, p < 0·001). These biases may influence treatment decisions, leading to assumptions that older patients are less capable of decision-making or prefer less aggressive treatments. Reference Neal, Morgan, Kenny, Ormerod and Reed21 The findings published in the literature along with the results from our survey emphasize the need for objective assessments to counteract age-based assumptions and ensure personalized, evidence-based treatment for older cancer patients.

Regarding the utilization of frailty screening tools within the context of RT, approximately one-third of our study respondents reported their implementation. Despite no specific data being available regarding the use of frailty screening tools within the scope of RT, an international survey addressing frailty assessment in cancer patients revealed a 37% utilization rate among European respondents. In this international survey, reasons cited for the non-utilization of screening tools included lack of awareness, time constraints and a perceived lack of associated benefits. Reference Banna, Cantale and Haydock22

The relationship between frailty and RT, as well as its potential role as a predictor of radiotoxicity and other clinical outcomes, remains inadequately understood. A cohort study found that frailty or vulnerability, as assessed by the G-8, VES-13, or Fried phenotype, was linked to higher rates of radiotoxicity, with areas under the curve of 0·86, 0·79, and 0·61, respectively. Reference Runzer-Colmenares, Urrunaga-Pastor, Aguirre, Reategui-Rivera, Parodi and Taype-Rondan23 A different prospective study investigating the Edmonton Frail Scale as a predictor of radiotoxicity in older patients found no significant statistical correlation. Reference Keenan, O’Brien, Ryan, Dunne and McArdle24 Data from head and neck cancer patients indicate that frailty, assessed using the CGA, Groningen Frailty Indicator, and G-8, as well as limitations in geriatric domains, were not linked to acute radiation-induced toxicity. Reference Bras, de Vries and Festen25 In patients with early-stage non-squamous cell lung cancer undergoing stereotactic RT, the modified frailty index (mFI) was associated with a reduced 3-year overall survival compared to those considered fit (37·3 vs 74·7%; p = 0·003). However, the higher mortality rate appeared to be primarily attributed to factors unrelated to lung cancer. Reference Franco, Chen and Chipidza26 Another study found that in this patient group, frailty, as assessed by the mFI, was a significant predictor of decreased overall survival (HR = 1·98, 95% CI 1·02–3·85, p = 0·04). Reference Raghavan, Shaverdian, Chan, Chu and Lee27 Data from a Greek RT department indicate that, among patients aged 75 or older receiving curative or palliative RT, a VES-13 score greater than 3 was linked to a 2·12-fold higher likelihood of an incomplete RT course, with this likelihood increasing to 3·34 times higher when the score exceeded 7· Reference Spyropoulou, Pallis, Leotsinidis and Kardamakis28 In urological cancer patients undergoing initial surgery or radiotherapy, those classified as frail based on the CGA had a higher risk of cancer-related hospitalizations compared to their fit counterparts (OR = 6·79, 95% CI 1·42–32·51). Reference Monfardini, Morlino and Valdagni29 These findings underscore the critical importance of assessing frailty status in older adults proposed for RT, as it may facilitate the identification of individuals at increased risk for adverse outcomes. Furthermore, such assessments could enable the development of personalized treatment strategies, in this manner optimizing the potential benefits of RT for each older patient.

In the context of interpreting the domains evaluated within RT, our findings indicate that social aspects are the most frequently assessed, with cognition following closely. Notably, while pertinent data specific to the geriatric assessment domains within radiation oncology are not presently available, recent insights derived from a survey conducted by the ASCO reveal that cognitive assessment prominently ranks among the top five domains evaluated in the geriatric assessment of older adults with cancer. In accordance with these results, the assessment of functional status and falls predominates among the frequently employed tools in geriatric assessment. Additionally, other tools were utilized, involving evaluations of weight loss, comorbidities, life expectancy, chemotherapy toxicity, mood, and noncancer mortality risk. Reference Dale, Williams and A30

The observed increase in older cancer patients attending RT departments, acknowledged by the majority of respondents, aligns with published projections. Over the next two decades, Europe is predicted to witness a notable increase in the number of new cancer cases annually, reaching 4·5 million, with 65% and 50% of patients aged over 65 and 75, respectively. By 2050, the typical cancer patient in Europe is expected to be 70 years of age or older, reflecting the significant demographic change. Reference Baumann, Ebert, Kurth, Bacchus and Overgaard31

Furthermore, most participants emphasized the critical need for further training in geriatric oncology. Comprehensive training is imperative for healthcare professionals, as it is crucial for them to recognize that chronological age inadequately predicts tolerance and outcomes in older adults with cancer, emphasizing the need for treatment decisions to reflect this understanding. Reference O’Donovan and Leech5 Expanding on this imperative, Morris et al. contribute valuable insights by providing an extensive compilation of global educational courses and strategies tailored to meet the upcoming training needs. Reference Morris, Thiruthaneeswaran, Lehman, Hasselburg and Turner12

The authors would like to highlight that this study has several limitations. The number of respondents falls short of the minimum threshold of 139 required to achieve a 95% confidence level with a 5% margin of error. Another limitation of this study is the use of closed-ended questions, which limited participants’ ability to elaborate on their responses. Including open-ended text boxes would have provided valuable data. Nevertheless, this pilot study underscores the necessity for further training in geriatric oncology and the importance of having dedicated geriatricians working alongside RO.

Conclusion

Our study highlights the imperative for enhanced training in geriatric oncology among radiation oncology professionals, given the prevailing lack of awareness, limited geriatric training and the need to recognize that chronological age poorly predicts tolerance and outcomes in older adults with cancer, emphasizing the necessity for treatment decisions to reflect this understanding.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/S1460396924000347.

Authorship

Edna Darlene Rodrigues ensured the integrity of the entire study, contributed to study concepts and design, conducted literature research, performed statistical analysis and participated in manuscript preparation and editing. Paulo Almeida served as a guarantor of integrity for the entire study, conducted literature research and participated in manuscript editing. Escarlata López Ramírez also served as a guarantor of integrity for the entire study, conducted literature research and participated in manuscript editing. Laetitia Teixeira served as a guarantor of integrity for the entire study, conducted literature research, performed statistical analysis and participated in manuscript editing.

Financial support

E.D.R. is funded by FCT—Fundação para a Ciência e Tecnologia and the European Social Fund, namely the Northern Regional Operational Programme (Norte 2020), the Centre’s Regional Operational Programme (Centro 2020) and the Alentejo Regional Operational Programme (Alentejo 2020)—(BD/151449/2021).

Competing interests

The authors of this paper have no conflicts of interest to disclose related to the findings presented.

References

Causas de morte - Cause of deaths. Instituto Nacional de Estatística/National statistics institute (INE); 2019 [09.01.2023]; Available from: https://www.ine.pt/ngt_server/attachfileu.jsp?look_parentBoui=484468013&att_display=n&att_download=y.Google Scholar
Costa Miranda, A, Mayer-da-Silva, A, Glória, L, Brito, C. Registo Oncológico Nacional De Todos Os Tumores Na População Residente Em PortugaL. 2021 [cited 2022 13.07.2021]; Available from: https://ron.min-saude.pt/media/2196/2021-0518_publica%C3%A7%C3%A3o-ron_2018.pdf.Google Scholar
Borras, JM, Lievens, Y, Dunscombe, P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol 2015; 116: 3844.CrossRefGoogle ScholarPubMed
Puts, MT, Tapscott, B, Fitch, M, et al. A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment. Cancer Treat Rev 2015; 41: 197215.CrossRefGoogle ScholarPubMed
O’Donovan, A, Leech, M. Personalised treatment for older adults with cancer: the role of frailty assessment. Tech Innov Patient Support Radiat Oncol 2020; 16: 3038.CrossRefGoogle ScholarPubMed
Thillainadesan, J, Scott, IA, Le Couteur, DG. Frailty, a multisystem ageing syndrome. Age Ageing 2020; 49: 758763.CrossRefGoogle ScholarPubMed
Council PM. Portuguese Medical Council Stattistics 2021. 2022 [07 Dec 2023]; Available from: https://ordemdosmedicos.pt/wp-content/uploads/2022/01/ESTATISTICAS_ESPECIALIDADES_2021.pdf.Google Scholar
Administration PCHS. Portuguese Central Health Service Administration - Specialty Placements. 2020 [7 Dec 2023]; Available from: https://www.acss.min-saude.pt/wp-content/uploads/2020/12/Lista-provisoria-colocados_Formacao-especializada_IM-2020-FE.pdf.Google Scholar
Administration PCHS. Portuguese Central Health Service Administration - Specialty Placements. 2018 [7 Dec 2023]; Available from: https://www.acss.min-saude.pt/wp-content/uploads/2016/09/Lista-Provisoria-Colocados-IM-2018-FE.pdf.Google Scholar
Administration PCHS. Portuguese Central Health Service Administration - Specialty Placements. 2019 [7 Dec 2023]; Available from: https://www.acss.min-saude.pt/wp-content/uploads/2016/09/Lista-provisoria-colocados_Formacao-especializada_IM-2019-FE.pdf.Google Scholar
Administration PCHS. Portuguese Central Health Service Administration - Specialty Placements. 2021 [7 Dec 2023]; Available from: https://www.acss.min-saude.pt/wp-content/uploads/2016/09/Lista-definitiva-colocados_Formacao-especializada_IM-2021-FE.pdf.Google Scholar
Morris, L, Thiruthaneeswaran, N, Lehman, M, Hasselburg, G, Turner, S. Are future radiation oncologists equipped with the knowledge to manage elderly patients with cancer? Int J Radiat Oncol Biol Phys 2017; 98: 743747.CrossRefGoogle ScholarPubMed
Terret, C, Droz, JP. Definition and outline on geriatric oncology. Prog Urol 2009; 19: S759.CrossRefGoogle ScholarPubMed
Fakhreddine, MH, Galvan, E, Pawlowski, J, Jones, WE. Communicating effectively with elderly cancer patients. Int J Radiat Oncol Biol Phys 2017; 98: 741742.CrossRefGoogle ScholarPubMed
Leifer, R, Bristow, B, Puts, M, et al. National survey among radiation oncology residents related to their needs in geriatric oncology. J Cancer Educ 2019; 34: 913.CrossRefGoogle ScholarPubMed
Loh, KP, Soto-Perez-de-Celis, E, Hsu, T, et al. What every oncologist should know about geriatric assessment for older patients with cancer: young international society of geriatric oncology position paper. J Oncol Pract 2018; 14: 8594.CrossRefGoogle ScholarPubMed
Popescu, T, Karlsson, U, Vinh-Hung, V, et al. Challenges facing radiation oncologists in the management of older cancer patients: consensus of the international geriatric radiotherapy group. Cancers 2019; 11: 371.CrossRefGoogle ScholarPubMed
Serdar, CC, Cihan, M, Yucel, D, Serdar, MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb) 2021; 31: 010502.CrossRefGoogle ScholarPubMed
Morris, L, Thiruthaneeswaran, N, Lehman, M, Hasselburg, G, Turner, S. Are future radiation oncologists equipped with the knowledge to manage elderly patients with cancer? Int J Radiat Oncol Biol Phys 2017; 98: 743747.CrossRefGoogle ScholarPubMed
Tranvag, EJ, Norheim, OF, Ottersen, T. Clinical decision making in cancer care: a review of current and future roles of patient age. BMC Cancer 2018; 18: 546.CrossRefGoogle Scholar
Neal, D, Morgan, JL, Kenny, R, Ormerod, T, Reed, MWR. Is there evidence of age bias in breast cancer health care professionals’ treatment of older patients? Eur J Surg Oncol 2022; 48: 24012407.CrossRefGoogle ScholarPubMed
Banna, GL, Cantale, O, Haydock, MM, et al. International survey on frailty assessment in patients with cancer. Oncologist 2022; 27: e796e803.CrossRefGoogle ScholarPubMed
Runzer-Colmenares, FM, Urrunaga-Pastor, D, Aguirre, LG, Reategui-Rivera, CM, Parodi, JF, Taype-Rondan, A. Frailty and vulnerability as predictors of radiotoxicity in older adults: a longitudinal study in Peru. Med Clin 2017; 149: 325330.CrossRefGoogle ScholarPubMed
Keenan, LG, O’Brien, M, Ryan, T, Dunne, M, McArdle, O. Assessment of older patients with cancer: edmonton Frail Scale (EFS) as a predictor of adverse outcomes in older patients undergoing radiotherapy. J Geriatric Oncol 2017; 8: 206210.CrossRefGoogle ScholarPubMed
Bras, L, de Vries, J, Festen, S, et al. Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: a prospective study. Oral Oncol 2021; 118: 105329.CrossRefGoogle Scholar
Franco, I, Chen, YH, Chipidza, F, et al. Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatric Oncol 2018; 9: 130137.CrossRefGoogle ScholarPubMed
Raghavan, G, Shaverdian, N, Chan, S, Chu, FI, Lee, P. Comparing outcomes of patients with early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy based on frailty status. Clin Lung Cancer 2018; 19: e759e66.CrossRefGoogle ScholarPubMed
Spyropoulou, D, Pallis, AG, Leotsinidis, M, Kardamakis, D. Completion of radiotherapy is associated with the vulnerable elders survey-13 score in elderly patients with cancer. J Geriatric Oncol 2014; 5: 2025.CrossRefGoogle ScholarPubMed
Monfardini, S, Morlino, S, Valdagni, R, et al. Follow-up of elderly patients with urogenital cancers: evaluation of geriatric care needs and related actions. J Geriatric Oncol 2017; 8: 289295.CrossRefGoogle ScholarPubMed
Dale, W, Williams, GR, A, RM, et al. How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American society of clinical oncology. JCO Oncol Pract 2021; 17: 336344.CrossRefGoogle Scholar
Baumann, M, Ebert, N, Kurth, I, Bacchus, C, Overgaard, J. What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond. Mol Oncol 2020; 14: 15771585.CrossRefGoogle Scholar
Figure 0

Figure 1. Representation of the age thresholds that radiation oncologists considered for defining a cancer patient as older.

Figure 1

Table 1. Comparison of responses between residents and consultants in radiation oncology

Figure 2

Figure 2. Comparison between responses within residents and consultants in radiation oncology (RO), regarding their training needs and preferences.

Supplementary material: File

Rodrigues Pinto et al. supplementary material

Rodrigues Pinto et al. supplementary material
Download Rodrigues Pinto et al. supplementary material(File)
File 967.3 KB